Iwamoto Yuichiro, Nakanishi Shuhei, Komi Masahiro, Kimura Yuto, Watanabe Yuki, Sasaki Taku, Nakao Erina, Kubo Masato, Sugisaki Toshitomo, Dan Kazunori, Okamoto Yui, Iwamoto Hideyuki, Sanada Junpei, Fushimi Yoshiro, Katakura Yukino, Kimura Tomohiko, Shimoda Masashi, Mune Tomoatsu, Kaku Kohei, Kaneto Hideaki
Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Okayama 701-0192, Japan.
Endocr J. 2025 Apr 1;72(4):375-385. doi: 10.1507/endocrj.EJ24-0397. Epub 2025 Jan 7.
Nerve conduction studies (NCS) are the standard method for diagnosing diabetic polyneuropathy. Because a clear association between handgrip strength and diabetic neuropathy can serve as a screening tool, the present study evaluated the association between handgrip strength and NCS and diabetes-related complications. A total of 436 patients with type 2 diabetes (T2D) who were admitted to our hospital between April 1, 2018 and March 31, 2023, and evaluated using Baba's diabetic neuropathy classification (BDC) were included. The participants were grouped by sex using the grip strength tertile method to assess correlations with the prevalence of diabetic microvascular complications in the high-handgrip group (HG), middle-handgrip group (MG), and low-handgrip group (LG). The percentage of BDC-0 was 65% in the HG, 54% in the MG, and 36% in the LG. Furthermore, none of the participants in the HG had BDC-3/4, whereas 4% in the MG and 15% in the LG had BDC-3/4. The morbidity progression of diabetic neuropathy was seen in the order of LG, MG, and HG (p < 0.001). Patients with T2D and advanced diabetic neuropathy had decreased handgrip strength. Early evaluation of BDC and other NCS should be considered if decreased handgrip strength is evident.
神经传导研究(NCS)是诊断糖尿病性多发性神经病的标准方法。由于握力与糖尿病性神经病变之间的明确关联可作为一种筛查工具,因此本研究评估了握力与NCS以及糖尿病相关并发症之间的关联。纳入了2018年4月1日至2023年3月31日期间入住我院并使用 Baba糖尿病神经病变分类法(BDC)进行评估的436例2型糖尿病(T2D)患者。采用握力三分位数法按性别对参与者进行分组,以评估高握力组(HG)、中握力组(MG)和低握力组(LG)中糖尿病微血管并发症患病率的相关性。HG组中BDC-0的比例为65%,MG组为54%,LG组为36%。此外,HG组中没有参与者为BDC-3/4,而MG组中有4%,LG组中有15%为BDC-3/4。糖尿病性神经病变的发病进展顺序为LG、MG和HG(p<0.001)。T2D和晚期糖尿病性神经病变患者的握力下降。如果握力明显下降,应考虑早期评估BDC和其他NCS。